Stock analysts at StockNews.com started coverage on shares of Veradigm (NASDAQ:MDRX – Get Free Report) in a research report issued on Thursday. The brokerage set a “hold” rating on the software maker’s stock.
Veradigm Stock Up 1.1 %
Shares of NASDAQ:MDRX opened at $9.60 on Thursday. Veradigm has a 1 year low of $5.01 and a 1 year high of $11.80. The stock’s fifty day moving average price is $9.98 and its 200-day moving average price is $9.73.
Institutional Inflows and Outflows
An institutional investor recently bought a new position in Veradigm stock. Innealta Capital LLC purchased a new stake in shares of Veradigm Inc. (NASDAQ:MDRX – Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 3,974 shares of the software maker’s stock, valued at approximately $38,000.
About Veradigm
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
See Also
- Five stocks we like better than Veradigm
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
- Why Are Stock Sectors Important to Successful Investing?
- Why Now Is the Ultimate Time to Invest in Oil Stocks
- What is a Stock Market Index and How Do You Use Them?
- Q4’s Most Upgraded Stocks: Promising Buys for 2025
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
